Clinical Trials Directory

Trials / Completed

CompletedNCT00749931

MarginProbe, a Device for Intraoperative Assessment of Margin Status in Breast Conservation Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
664 (actual)
Sponsor
Dune Medical Devices · Industry
Sex
Female
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to show that addition of device use to a routine breast cancer tumor excision procedure is beneficial and assists the surgeon in correctly determining the extent of excision.

Detailed description

The study is a prospective, multi-center, randomized, double arm study demonstrating the effectiveness of the device in adjunctive use for locating the tissue for additional excision following primary specimen excision. One arm is a "Standard of Care" (SOC) Control group and the other arm a "Device+SOC" group.In the "Device +SOC" group the surgeon will use the MarginProbe device on the tissue specimen removed during the surgical procedure.The surgeon will use the results derived from the device and other routine assessments to decide if it is necessary to remove some additional breast tissue.

Conditions

Interventions

TypeNameDescription
DEVICEMarginProbeDevice use to assess margin status of the excised specimen surface.
PROCEDURELumpectomyStandard of care lumpectomy procedure

Timeline

Start date
2008-10-01
Primary completion
2010-03-01
Completion
2010-06-01
First posted
2008-09-09
Last updated
2014-06-27
Results posted
2014-06-27

Locations

21 sites across 2 countries: United States, Israel

Source: ClinicalTrials.gov record NCT00749931. Inclusion in this directory is not an endorsement.